Full-Time

Medical Technologist/MLT/Lab Technician

Generalist, PRN

Confirmed live in the last 24 hours

Cleveland Clinic

Cleveland Clinic

Non-profit academic medical center providing healthcare

No salary listed

Junior, Mid

Company Does Not Provide H1B Sponsorship

Jensen Beach, FL, USA

Position is in-person at CC Martin Hospital South in Stuart, Florida.

Category
Diagnostics & Laboratory Professionals
Medical, Clinical & Veterinary
Requirements
  • Associate degree in a laboratory science, or medical laboratory technology from an accredited institution
  • OR Bachelor’s degree in a chemical, physical, biological or clinical laboratory science or medical technology from a four-year college or university
  • OR meets the CLIA qualifications for high complexity testing personnel grandfathering clauses
  • Education outside of the United States requires diploma/transcripts translated into English and proof of foreign equivalency from an HHS approved agency or nationally recognized organization such as NACES (National Association Credential Evaluation Services, Inc.) or AICE (Association of International Credential Evaluators, Inc.)
  • Licensed in the State of Florida at the technologist levels
  • One or more specialties: Microbiology, Immunohematology or all licenses
Responsibilities
  • Follow laboratory procedures for specimen handling and processing, test analyses, reporting and maintaining records of patient test results
  • Maintain regulatory knowledge and awareness as it pertains to specific job duties
  • Adhere to the laboratory’s quality control policies, document all quality control activities, instrument and procedural calibrations and maintenance performed
  • Assume responsibility for and take action regarding any quality control or quality assurance issues as it pertains to specific job duties
  • Maintain instruments and equipment in accordance with manufacturer’s specifications
  • Assume responsibility for good documentation practices and maintain clear and legible records
  • Perform proficiency testing in compliance with Clinical Laboratory Improvement Amendments (CLIA) regulations i.e. analyze proficiency survey sample in the same manner as a patient specimens, no communication with other CLIA laboratories, complete record retention and accurate documentation and result reporting
  • Assume responsibility for participation in continuing education, professional development and required annual competency assessment
  • Follow the laboratory's established policies and procedures whenever test systems are not within the laboratory's established acceptable levels of performance
  • Identify problems that may adversely affect test performance or reporting of test results and either must correct the problems or immediately notify the General Supervisor, Technical Supervisor, Clinical Consultant, or Laboratory Director
  • May function as an educator and provides instruction and training in theory, technical skills, safety protocols, and the application of laboratory test protocols to students, employees, residents, etc.
Desired Qualifications
  • Certification as a Medical Technologist (MT, MLT or MLS) or certification eligible, from the American Society of Clinical Pathology (ASCP)

Cleveland Clinic is a non-profit academic medical center that provides high-quality clinical and hospital care, including routine check-ups, specialized treatments, and life-saving surgeries. It offers virtual visits and second opinions to improve accessibility and operates multiple locations in Ohio, Florida, Abu Dhabi, and Canada. The clinic generates revenue primarily through patient services and enhances the patient experience with resources like MyChart for health record management. Cleveland Clinic aims to deliver exceptional medical care, advance medical research, and educate future healthcare professionals.

Company Size

N/A

Company Stage

Grant

Total Funding

$74.7M

Headquarters

Cleveland, Ohio

Founded

1921

Simplify Jobs

Simplify's Take

What believers are saying

  • Increased investment in AI healthcare solutions enhances Cleveland Clinic's data analysis capabilities.
  • Neuromodulation therapies present opportunities for treating conditions like obstructive sleep apnea.
  • Collaboration on virtual neighborhoods using EHR data offers community health insights.

What critics are saying

  • Competition from AI healthcare companies may challenge Cleveland Clinic's data management.
  • Neuromodulation therapies could shift patient preferences from traditional treatments.
  • Developing virtual neighborhoods with EHR data may pose data privacy challenges.

What makes Cleveland Clinic unique

  • Cleveland Clinic offers comprehensive medical services, including virtual visits and second opinions.
  • It operates globally with facilities in Ohio, Florida, Abu Dhabi, and Canada.
  • The clinic supports healthcare providers with resources like DrConnect and eRadiology.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Professional Development Budget

Mental Health Support

Company News

Finsmes
Dec 12th, 2024
1m Raises $10M in Series A Funding

1m raises $10M in Series A funding.

Hit Consultant
Oct 24th, 2024
Dyania Health Secures $10M for AI-Powered Chart Review

Dyania Health, an AI-powered healthcare data company, today announced the close of its $10 million Series A funding round led by Health..

PR Newswire
Aug 21st, 2024
Xii Medical Raises $45 Million In Series B Financing To Advance Best-In-Class Neuromodulation Therapy For Obstructive Sleep Apnea

Omega Funds and Intuitive Ventures join top-tier syndicate of healthcare investors to support ongoing clinical activitiesUNION CITY, Calif., Aug. 21, 2024 /PRNewswire/ -- XII Medical, Inc., a clinical-stage medical technology company developing innovative therapies for obstructive sleep apnea, today announced the closing of a $45 million Series B equity financing. The financing was led by Omega Funds and joined by new investor Intuitive Ventures. Existing investors also participated, including founding investor Cleveland Clinic, Ajax Health, Longview Ventures (an affiliate of Broadview Ventures), Aperture Venture Partners, JobsOhio Growth Capital Fund and an undisclosed strategic investor. Funds will be utilized to further product and clinical development. XII Medical has developed a state-of-the-art, patient-centric neuromodulation therapy designed to enhance quality of life for the millions of people suffering from obstructive sleep apnea.Obstructive sleep apnea (OSA) is a disorder in which the muscles in the throat temporarily relax, causing blockage of the airway during sleep

Finsmes
Aug 6th, 2024
Neurotherapia Raises $12.3M In Series B Funding

NeuroTherapia, a Cleveland, OH-based clinical-stage company focused on developing therapies for neurodegenerative diseases, raised $12.3M in Series B funding.The round was led by Cleveland Clinic, and included all previous investors, Brain Trust Accelerator Fund II, Dolby Family Ventures and the Alzheimer’s Drug Discovery Foundation (ADDF) as well as new investors, Foundation for a Better World and CRUINT. Led by President and CEO Tony Giordano, NeuroTherapia is a clinical-stage biotechnology company developing oral, small-molecule drugs to address neuro-inflammatory conditions of the central nervous system (CNS), including Alzheimer’s disease, Parkinson’s disease, amyotrophic lateral sclerosis, and other CNS conditions. NeuroTherapia is developing therapeutics that inhibit microglia cells, which are known to express proteins that drive inflammation in the CNS, without affecting the clearance of toxic beta amyloid.The company intends to use the funds for the continued clinical development of NTRX-07, an orally available cannabinoid receptor agonist, for the treatment of Alzheimer’s disease (AD). NeuroTherapia will continue to raise additional funds for its second close in six months, which will enable development of a recently discovered second generation molecule for a separate indication in which neuroinflammation plays a major role.FinSMEs06/08/2024

PR Newswire
Aug 1st, 2023
Enspire DBS Therapy Announces $17.6 Million Series B Financing to Advance the Development of Deep Brain Stimulation (DBS) plus Rehabilitation for Stroke Patients

/PRNewswire/ -- Enspire DBS Therapy, Inc., (Enspire) a clinical stage company developing an implantable neuromodulation therapy for post-stroke recovery,...